S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
BOLT · Bolt Biotherapeutics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Bolt Biotherapeutics Inc (BOLT)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$4.14
+0.06
(+1.47%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$4.14
$4.14
$4.14
52-WEEK RANGE
$4.14
$3.10
$7.20
What's happening
- BOLT is up 1.47% today, trading at $4.14. — Live quote
- Volume today (221) is well below its 3-month average of 27,410. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-4.57 actual vs. $-3.45 estimated (-32.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 5
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
BOLT
-21.18%
vs S&P 500
-33.95%
1-YEAR RETURN
BOLT
-26.45%
vs S&P 500
-41.01%
6-MONTH RETURN
BOLT
-10.39%
3-MONTH RETURN
BOLT
+7.21%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-4.57
Est. $-3.45
MISS -32.3%
2026-04-26 (Q1 2026)
$-4.31
Est. $-2.91
MISS -48.3%
2026-01-26 (Q4 2025)
$-3.84
Est. $-6.23
BEAT +38.4%
2025-10-26 (Q3 2025)
$-3.72
Est. $-5.90
BEAT +37.0%
Valuation Measures & Ratios
Enterprise Value4-$4.6M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.77
Price / Book70.59
EV4 / Revenue-0.97
EV4 / EBITDA—
Profit Margin-611.47%
Operating Margin-654.53%
Return on Equity (ROE8)-126.23%
Return on Assets (ROA9)-54.70%
Avg Volume (3M)27,410
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $6.5M | $6.9M | $10.0M | $11.1M | $15.4M |
| P/E | -0.21 | -0.20 | -0.24 | -0.20 | -0.26 |
| Price/Sales | 1.62 | 1.33 | 1.57 | 2.04 | 1.73 |
| Price/Book | 0.51 | 0.35 | 0.31 | 0.29 | 0.33 |
| EV/Revenue | -1.59 | -0.90 | -1.23 | 0.27 | 0.79 |
| EV/EBITDA | 0.20 | 0.13 | 0.18 | — | — |
| ROE | -242.63% | -171.47% | -130.59% | -144.10% | -124.38% |
| ROA | -76.02% | -70.77% | -64.44% | -74.14% | -67.81% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short25,736
Change from Prior Settlement+39.22%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-06; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -99.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -611.5%. Finnhub fundamentals ↗
- Trailing 52-week price return is -26.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BOLT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0K | $26.0K | $2.2M | $1.8M | $1.2M | $1.1M | $1.3M | $5.3M |
| Operating income | -$8.4M | -$7.6M | -$7.7M | -$9.2M | -$12.1M | -$16.4M | -$22.6M | -$17.1M |
| Net income | -$7.7M | -$7.2M | -$7.1M | -$8.6M | -$11.0M | -$15.2M | -$21.2M | -$10.8M |
| EPS (diluted) | $-4.57 | $-4.31 | $-3.72 | $-4.46 | $-5.76 | $-7.93 | $-11.12 | $-0.28 |
| EPS (basic) | $-4.57 | $-4.31 | $-3.72 | $-4.46 | $-5.76 | $-7.93 | $-11.12 | $-0.28 |
| Operating margin | -$167.5K | -$29.2K | -$355 | -$511 | -$991 | -$1.4K | -$1.8K | -$324 |
| Net margin | -$154.4K | -$27.9K | -$329 | -$475 | -$903 | -$1.3K | -$1.7K | -$205 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $40.3M | $48.0M | $56.7M | $65.1M | $75.5M | $85.9M | $99.6M | $109.3M |
| Total liabilities | $27.7M | $28.2M | $30.2M | $33.0M | $36.7M | $39.1M | $42.4M | $37.3M |
| Stockholders' equity | $12.6M | $19.8M | $26.5M | $32.1M | $38.8M | $46.8M | $57.2M | $72.0M |
| Total current assets | $20.6M | $25.8M | $30.3M | $35.6M | $38.3M | $42.5M | $50.8M | $57.1M |
| Total current liabilities | $7.9M | $7.3M | $8.4M | $10.0M | $12.3M | $13.6M | $15.9M | $18.1M |
| Cash & equivalents | $12.9M | $11.6M | $11.7M | $17.8M | $9.6M | $8.4M | $7.2M | $9.4M |
| Marketable securities (current) | $4.7M | $11.3M | $15.8M | $14.2M | $25.2M | $30.4M | $40.1M | $44.4M |
| Marketable securities (non-current) | $509.0K | $1.0M | $4.3M | $6.9M | $13.7M | $19.1M | $22.9M | $30.6M |
| Property, plant & equipment | $571.0K | $1.0M | $1.2M | $1.5M | $1.7M | $2.1M | $3.1M | $3.6M |
| Other non-current assets | $87.0K | $112.0K | $138.0K | $179.0K | $222.0K | $51.0K | $62.0K | $287.0K |
| Accounts payable | $868.0K | $1.7M | $1.4M | $1.5M | $1.9M | $1.5M | $1.5M | $1.5M |
| Deferred revenue (current) | $819.0K | $630.0K | $449.0K | $1.9M | $2.5M | $3.1M | $3.0M | $2.0M |
| Other non-current liabilities | $132.0K | $158.0K | $132.0K | $133.0K | $133.0K | $132.0K | $0 | $0 |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K |
| Retained earnings | -$475.7M | -$468.0M | -$460.8M | -$454.1M | -$447.0M | -$438.4M | -$427.4M | -$411.5M |
| Accumulated other comprehensive income (loss) | -$44.0K | -$11.0K | -$21.0K | -$10.0K | -$6.0K | $40.0K | $97.0K | $205.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.5M | -$8.0M | -$7.2M | -$9.7M | -$9.6M | -$13.4M | -$14.4M | -$14.0M |
| Investing cash flow | $7.8M | $7.9M | $1.1M | $17.9M | $10.8M | $14.6M | $12.2M | $17.1M |
| Financing cash flow | $19.0K | $6.0K | $5.0K | $0 | $14.0K | $0 | $29.0K | $0 |
| Free cash flow | -$6.6M | — | -$7.2M | -$9.8M | -$9.6M | — | -$14.4M | -$14.0M |
| Capital expenditures | $13.0K | — | $0 | $72.0K | $0 | — | $0 | $41.0K |
| Depreciation & amortization | $171.0K | $203.0K | $255.0K | $290.0K | $347.0K | $399.0K | $426.0K | $440.0K |
| Share-based compensation | $552.0K | $545.0K | $1.0M | $407.0K | $625.0K | $709.0K | $1.2M | $1.1M |
| Purchases of investments | $0 | $1.2M | $11.8M | $1.7M | $14.5M | $992.0K | $13.3M | $20.3M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $7.7M | $7.7M | $7.9M | $5.7M | $1.3M |
| Operating income | -$36.1M | -$73.0M | -$76.2M | -$90.3M | -$92.8M |
| Net income | -$33.4M | -$63.1M | -$69.2M | -$88.1M | -$98.6M |
| EPS (diluted) | $-17.85 | $-33.06 | $-1.83 | $-2.36 | $-2.97 |
| EPS (basic) | $-17.85 | $-33.06 | $-1.83 | $-2.36 | $-2.97 |
| Operating margin | -$469 | -$950 | -$967 | -$1.6K | -$7.4K |
| Net margin | -$434 | -$821 | -$879 | -$1.5K | -$7.8K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $56.7M | $99.6M | $159.8M | $227.8M | $307.7M |
| Total liabilities | $30.2M | $42.4M | $47.0M | $56.3M | $57.6M |
| Stockholders' equity | $26.5M | $57.2M | $112.7M | $171.5M | $250.1M |
| Total current assets | $30.3M | $50.8M | $105.7M | $172.7M | $189.2M |
| Total current liabilities | $8.4M | $15.9M | $20.5M | $23.1M | $21.3M |
| Cash & equivalents | $11.7M | $7.2M | $10.8M | $9.2M | $27.4M |
| Marketable securities (current) | $15.8M | $40.1M | $91.4M | $159.6M | $158.8M |
| Marketable securities (non-current) | $4.3M | $22.9M | $26.4M | $23.9M | $85.3M |
| Property, plant & equipment | $1.2M | $3.1M | $5.0M | $6.5M | $6.2M |
| Other non-current assets | $138.0K | $62.0K | $1.8M | $1.0M | $1.0M |
| Accounts payable | $1.4M | $1.5M | $3.0M | $3.6M | $3.6M |
| Deferred revenue (current) | $449.0K | $3.0M | $2.2M | $2.0M | $2.9M |
| Other non-current liabilities | $132.0K | $0 | $43.0K | $42.0K | $210.0K |
| Common stock & paid-in capital | $0 | $0 | $0 | $0 | $0 |
| Retained earnings | -$460.8M | -$427.4M | -$364.3M | -$295.1M | -$207.0M |
| Accumulated other comprehensive income (loss) | -$21.0K | $97.0K | $37.0K | -$919.0K | -$321.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$39.9M | -$61.3M | -$69.5M | -$76.5M | -$57.1M |
| Investing cash flow | $44.3M | $57.6M | $71.0M | $57.9M | -$232.2M |
| Financing cash flow | $19.0K | $108.0K | $253.0K | $503.0K | $311.1M |
| Free cash flow | -$39.9M | -$61.3M | -$69.7M | -$78.5M | -$59.4M |
| Capital expenditures | $72.0K | $41.0K | $206.0K | $2.0M | $2.3M |
| Depreciation & amortization | $1.3M | $1.8M | $1.9M | $1.7M | $1.2M |
| Share-based compensation | $2.8M | $7.4M | $9.2M | $9.6M | $8.5M |
| Purchases of investments | $29.0M | $88.9M | $165.0M | $180.7M | $313.4M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BOLT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-06-06 to 2026-09-18
Recent transactions
- Insiders have net sold 37,438 shares over the last 182 days, across 2 purchases and 9 sales.
- Most recent: Yonehiro Grant (Chief Operating Officer) — Open market sale of 6,850 shares on 2026-09-18.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)1,146 sh(2 txns)
Sales (open market)38,584 sh(9 txns)
Net Shares-37,438
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Yonehiro Grant | Chief Operating Officer | Open market sale | 2026-09-18 | 6,850 |
| Nemec Sarah | Senior VP, Finance and PAO | Open market sale | 2026-09-18 | 4,077 |
| Quinn William P. | President, CEO and CFO | Open market sale | 2026-09-18 | 9,132 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-18 | Yonehiro Grant | Chief Operating Officer | Open market sale | 6,850 | $3.24 |
| 2026-09-18 | Nemec Sarah | Senior VP, Finance and PAO | Open market sale | 4,077 | $3.24 |
| 2026-09-18 | Quinn William P. | President, CEO and CFO | Open market sale | 9,132 | $3.24 |
| 2026-09-17 | Yonehiro Grant | Chief Operating Officer | Open market sale | 4,909 | $3.32 |
| 2026-09-17 | Nemec Sarah | Senior VP, Finance and PAO | Open market sale | 2,922 | $3.32 |
| 2026-09-17 | Quinn William P. | President, CEO and CFO | Open market sale | 6,545 | $3.32 |
| 2026-09-16 | Yonehiro Grant | Chief Operating Officer | Open market sale | 1,417 | $3.77 |
| 2026-09-16 | Nemec Sarah | Senior VP, Finance and PAO | Open market sale | 843 | $3.77 |
| 2026-09-16 | Quinn William P. | President, CEO and CFO | Open market sale | 1,889 | $3.77 |
| 2026-06-05 | Nemec Sarah | Senior VP, Finance and PAO | Open market purchase | 509 | $3.88 |
| 2026-06-05 | Quinn William P. | President, CEO and CFO | Open market purchase | 637 | $3.88 |
| 2025-12-05 | Quinn William P. | President, CEO and CFO | Open market purchase | 125 | $4.61 |
| 2025-12-05 | Nemec Sarah | Senior VP, Finance and PAO | Open market purchase | 125 | $4.61 |
| 2025-10-22 | Nemec Sarah | Senior VP, Finance and PAO | Grant / award | 23,000 | $0.00 |
| 2025-10-22 | Yonehiro Grant | Chief Operating Officer | Grant / award | 30,000 | $0.00 |
| 2025-10-22 | Quinn William P. | President, CEO and CFO | Grant / award | 40,000 | $0.00 |
| 2025-06-06 | Nemec Sarah | Senior VP, Finance and PAO | Open market purchase | 125 | $5.49 |
| 2025-06-06 | Quinn William P. | President, CEO and CFO | Open market purchase | 125 | $5.49 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-06 | 8-K | 2026-10-01 | View on SEC.gov → |
| 2026-09-21 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-21 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-21 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 4 | 2026-06-10 | View on SEC.gov → |
| 2026-06-11 | 8-K | 2026-06-11 | View on SEC.gov → |
Recent news
Headlines about BOLT (Bolt Biotherapeutics, Inc.). Links open the publisher — we don’t host full articles.
-
Owners Speak Out! What's the Deal with the Yamaha Bolt, Anyway!? [Owner Review Summary]
Webike Japan · 2026-10-22 -
Lucid’s 25,000 Bolt robotaxis will run on Nvidia’s self-driving software
Electrek · 2026-10-21 -
Lucid Robotaxis for Bolt Start With ‘Tens of Vehicles’ in Madrid in 2027
Electric Vehicles · 2026-10-21 -
Bolt, Nvidia to kickstart driverless taxi programme in Madrid during 2027
marketscreener.com · 2026-10-21 -
Usain Bolt pledged J$10 million with Puma to help restore damaged schools across Jamaica
The Times of India · 2026-10-21 -
BOLT Q2 2026 Earnings: Wider-Than-Expected Loss Per Share, Yet Shares Move Higher - Revenue Beat Analysis
https://www.dars.gov.et/ · 2026-10-20 -
Bolt Targets Rider Loyalty in Kenya with KSh 899 Annual Subscription
https://streamlinefeed.co.ke/ · 2026-10-19 -
Historic First As Chinese Robot Beats Usain Bolt's 100m World Record At Beijing Games | BBC News Tori Spelling (zIXEEgO2g0)
Unisba Media · 2026-10-17
No headlines in this category right now — try “All”.